Cancer-related deaths among different treatment options in chronic coronary artery disease: Results of a 6-year follow-up of the MASS II study

Coronary Artery Disease

Volumn 23, Issue 2, 2012, Pages 79-84

  Vieira, Ricardo D ^a   Pereira, Alexandre C ^a   Lima, Eduardo G ^a   Garzillo, Cibele L ^a   Rezende, Paulo Cury ^a   Favarato, Desiderio ^a   Hueb, Alexandre C ^a   Gersh, Bernard J ^b   Ramires, José A F ^a   Hueb, Whady ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Mayo Clinic Foudation   (United States)

Author keywords

Angioplasty; Cancer; Coronary artery disease; Coronary revascularization; Death

Indexed keywords

CANCER MORTALITY; CAUSE OF DEATH; CHRONIC DISEASE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OVERALL SURVIVAL; POST HOC ANALYSIS; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; BRAZIL; CAUSE OF DEATH; CHRONIC DISEASE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857235525     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834f112a     Document Type: Review

References (18)

1. BodenWE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, KostukWJ, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-1516. (Pubitemid 46588415)
2. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360:2503-2515.
3. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007; 297:1985-1991. (Pubitemid 46740350)
4. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46:575-581. (Pubitemid 41132680)
5. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJL, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6:1-23.
6. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, et al. The Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multi-vessel coronary artery disease: 1-year results. J Am Coll Cardiol 2004; 43:1743-1751. (Pubitemid 38622508)
7. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, et al. BARI Investigators. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry. Circulation 2000; 101:2682-2689. (Pubitemid 30390570)
8. Holmes DR Jr, Kip KE, Kelsey SF, Detre KM, Rosen AD. Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. J Am Coll Cardiol 1997; 30:881-887. (Pubitemid 27435876)
9. Darwazah AK, Shehata S. Detrimental effect of cardiopulmonary bypass (CPB) on malignant disease. J Cardiothorac Surg 2011; 6:13.
10. Kucukarslan N, Tatar T, Uzun M, Yavuz I, Ozal E, Tatar H. Coronary artery bypass surgery in patients with malignancy: a single-center study with comparison to patients without malignancy. J Card Surg 2009; 24:151-155.
11. Platell C. Influence of cardiopulmonary bypass surgery on cancer-specific survival rate of patients with colorectal cancer. Dis Colon Rectum 1998; 41:1371-1375. (Pubitemid 28519218)
12. Peter H, Manos JP, Graber CD, Lee WH Jr. Depression of immunologic surveillance by pump-oxygenation perfusion. J Surg Res 1969; 9:587-593.
13. Butler J, Rocker GM,Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55:552-559. (Pubitemid 23060844)
14. Panagiotopoulos I, Palatianos G, Michalopoulos A, Chatzigeorgiou A, Prapas S, Kamper EF. Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization. J Clin Lab Anal 2010; 24:389-398.
15. Von Muller L, Klemm A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006; 12:1517-1522. (Pubitemid 44570892)
16. Cook CH. Cytomegalovirus reactivation in 'immunocompetent' patients: a call for scientific prophylaxis. J Infect Dis 2007; 196:1273-1275. (Pubitemid 351411995)
17. Zahariadis G, Jerome KR, Corey L. Herpes simplex virus-associated sepsis in a previously infected immunocompetent adult. Ann Intern Med 2003; 139:153-154. (Pubitemid 38129110)
18. Pamuk ON, Pamuk GE, Celik AF, Ozturk R, Aktuglu Y. Herpes simplex virus esophagitis in an immunocompetent host with sepsis. Am J Gastroeneterol 2001; 96:2264-2266. (Pubitemid 32660934)